MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Revenue
$1,039K
Net Income
-$23,283K
Net Profit Margin
-2240.90%
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
License agreement revenue
1,039 2,711* NaN NaN
Research and development
17,903 77,694* 20,347 NaN
General and administrative
7,865 8,776* 5,538 NaN
Total operating expenses
25,768 86,470* 25,885 NaN
Loss from operations
-24,729 -83,759* -25,885 -21,030
Interest income
1,446 489* 1,278 313
Interest expense
0 576* 0 1,073
Loss before provision for income taxes
NaN -83,846* NaN NaN
Provision for income taxes
NaN 500* NaN NaN
Total other income (expense)
1,446 NaN 1,278 -760
Net loss and comprehensive loss
-23,283 -84,346 -24,607 -21,790
Net loss and comprehensive loss
-23,283 -84,346 -24,607 -21,790
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net loss andcomprehensive loss-$23,283K Interest income$1,446K Net loss andcomprehensive loss-$23,283K Total other income(expense)$1,446K Loss from operations-$24,729K License agreementrevenue$1,039K Total operatingexpenses$25,768K Research and development$17,903K General andadministrative$7,865K

CRESCENT BIOPHARMA, INC. (CBIO)

CRESCENT BIOPHARMA, INC. (CBIO)